Dr Reddys Drug Patent Portfolio
Dr Reddys owns 1 orange book drug protected by 1 US patent Given below is the list of Dr Reddys's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10993952 | Stable ready to use cyclophosphamide liquid formulations | 15 Feb, 2036 | Active |
Latest Legal Activities on Dr Reddys's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Dr Reddys.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 May, 2024 | US10849916 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 May, 2024 | US10993952 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 12 Jul, 2022 | US11382923 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Jul, 2022 | US11382923 |
|
Email Notification
Critical
| 23 Jun, 2022 | US11382923 |
|
Issue Notification Mailed
Critical
| 22 Jun, 2022 | US11382923 |
| Dispatch to FDC | 08 Jun, 2022 | US11382923 |
|
Application Is Considered Ready for Issue
Critical
| 08 Jun, 2022 | US11382923 |
|
Issue Fee Payment Received
Critical
| 06 Jun, 2022 | US11382923 |
|
Issue Fee Payment Verified
Critical
| 06 Jun, 2022 | US11382923 |
| Letter Accepting Correction of Inventorship Under Rule 1.48 | 06 May, 2022 | US11382923 |
|
Email Notification
Critical
| 06 May, 2022 | US11382923 |
| Filing Receipt - Updated | 06 May, 2022 | US11382923 |
| Miscellaneous Incoming Letter | 03 May, 2022 | US11382923 |
|
Email Notification
Critical
| 25 Apr, 2022 | US11382923 |
Dr Reddys's Family Patents
Dr Reddys drugs have patent protection in a total of 3 countries. It's US patent count contributes only to 50.0% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Dr Reddys Drug List
Given below is the complete list of Dr Reddys's drugs and the patents protecting them.
1. Cyclophosphamide
Cyclophosphamide is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10993952 | Stable ready to use cyclophosphamide liquid formulations |
15 Feb, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyclophosphamide's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List